Olympia Fields, IL, United States of America

Charles D Bossinger


Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Olympia Fields, IL (US) (1977 - 1980)
  • White Plains, NY (US) (1983)

Company Filing History:


Years Active: 1977-1983

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Charles D. Bossinger: Innovator in Antihypertensive Polypeptides

Introduction

Charles D. Bossinger is a notable inventor based in Olympia Fields, IL (US). He has made significant contributions to the field of biochemistry, particularly in the development of antihypertensive polypeptides. His work has led to the issuance of several patents that showcase his innovative approach to peptide synthesis.

Latest Patents

Bossinger holds 3 patents, with his latest inventions focusing on the synthesis of biologically active peptides. One of his notable patents involves antihypertensive polypeptides, specifically peptides with the structure that includes ALA-GLU-CH.sub.2 - R at one end of an amino acid chain. In this context, R represents the resin, while ALA and GLU denote the residues of the amino acids alanine and glutamic acid. Additionally, he has developed resin peptides that include ACTH.sup.1-28, which exhibit adrenocorticotropic activity, along with the processes for their preparation.

Career Highlights

Throughout his career, Bossinger has worked with prominent companies in the pharmaceutical industry. He has been associated with Armour Pharmaceutical Company and Armour and Company, where he contributed to various research and development projects. His expertise in peptide synthesis has been instrumental in advancing therapeutic options in the medical field.

Collaborations

Some of his notable coworkers include Robert L. Colescott and Emil Kaiser. Their collaborative efforts have further enriched the research environment in which Bossinger has thrived.

Conclusion

Charles D. Bossinger's innovative work in the field of antihypertensive polypeptides has made a lasting impact on biochemistry and pharmaceutical research. His patents reflect a commitment to advancing medical science through the development of effective peptide-based therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…